Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (361-370 of 511) with videos related to

Pageof 52
Sort By:
Gut|March 28, 2018
Circulating microbiome in blood of different circulatory compartmentsRobert Schierwagen, Camila Alvarez-Silva, Mette Simone Aae Madsen, et al.
Frontiers in Immunology|August 1, 2020
The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver DiseaseRobert Schierwagen, Frank E Uschner, Cristina Ortiz, et al.
Journal of Hepatocellular Carcinoma|December 25, 2023
Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver TransplantationThi Phuong Thao Hoang, Philipp Schindler, Nikolaus Börner, et al.
Frontiers in Molecular Biosciences|September 13, 2021
The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic SteatohepatitisSandra Torres, Maximilian J Brol, Fernando Magdaleno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2020
Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunctionFrank E Uschner, Kathleen Glückert, Rafael Paternostro, et al.
The Journal of Clinical Investigation|January 31, 2020
Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancerPeter Dietrich, Laura Wormser, Valerie Fritz, et al.
International Journal of Molecular Sciences|October 14, 2023
Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced ObesityJudith Sommer, Hanna Ehnis, Tatjana Seitz, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 13, 2019
Combination of CCl<sub>4</sub> with alcoholic and metabolic injuries mimics human liver fibrosisMaximilian Joseph Brol, Felicitas Rösch, Robert Schierwagen, et al.
Alimentary Pharmacology & Therapeutics|January 15, 2019
Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinomaMaria Angeles Gonzalez-Carmona, Maximilian Bolch, Christian Jansen, et al.
Scientific Reports|June 30, 2016
The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injuryLinda Sevelsted Møller, Annette Dam Fialla, Robert Schierwagen, et al.
Pageof 52

Showing results (361-370 of 511) with videos related to

Sort By:
Pageof 52
Gut|March 28, 2018
Circulating microbiome in blood of different circulatory compartmentsRobert Schierwagen, Camila Alvarez-Silva, Mette Simone Aae Madsen, et al.
Frontiers in Immunology|August 1, 2020
The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver DiseaseRobert Schierwagen, Frank E Uschner, Cristina Ortiz, et al.
Journal of Hepatocellular Carcinoma|December 25, 2023
Imaging-Derived Biomarkers Integrated with Clinical and Laboratory Values Predict Recurrence of Hepatocellular Carcinoma After Liver TransplantationThi Phuong Thao Hoang, Philipp Schindler, Nikolaus Börner, et al.
Frontiers in Molecular Biosciences|September 13, 2021
The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic SteatohepatitisSandra Torres, Maximilian J Brol, Fernando Magdaleno, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2020
Combination of phosphodiesterase-5-inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunctionFrank E Uschner, Kathleen Glückert, Rafael Paternostro, et al.
The Journal of Clinical Investigation|January 31, 2020
Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancerPeter Dietrich, Laura Wormser, Valerie Fritz, et al.
International Journal of Molecular Sciences|October 14, 2023
Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced ObesityJudith Sommer, Hanna Ehnis, Tatjana Seitz, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 13, 2019
Combination of CCl<sub>4</sub> with alcoholic and metabolic injuries mimics human liver fibrosisMaximilian Joseph Brol, Felicitas Rösch, Robert Schierwagen, et al.
Alimentary Pharmacology & Therapeutics|January 15, 2019
Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinomaMaria Angeles Gonzalez-Carmona, Maximilian Bolch, Christian Jansen, et al.
Scientific Reports|June 30, 2016
The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injuryLinda Sevelsted Møller, Annette Dam Fialla, Robert Schierwagen, et al.
Pageof 52